FR2900155B1 - Hydrolisat de cartilage aviaire, procede d'obtention et utilisations - Google Patents

Hydrolisat de cartilage aviaire, procede d'obtention et utilisations

Info

Publication number: FR2900155B1
Authority: FR; France
Prior art keywords: cartilage; hydrolyzate; reaction mixture; avian; hydroxyproline
Prior art date: 2006-04-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

FR0603547A

Other languages

English (en)

Other versions

FR2900155A1 (fr

Inventor

Eric Vouland

Celine Berger

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Diana Food Fr

Original Assignee

Diana Naturals SAS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-04-21

Filing date

2006-04-21

Publication date

2008-06-27

2006-04-21 Application filed by Diana Naturals SAS filed Critical Diana Naturals SAS

2006-04-21 Priority to FR0603547A priority Critical patent/FR2900155B1/fr

2006-06-19 Priority to US11/455,239 priority patent/US7671041B2/en

2007-04-19 Priority to PCT/EP2007/053850 priority patent/WO2007122179A1/fr

2007-04-19 Priority to AT07728309T priority patent/ATE459371T1/de

2007-04-19 Priority to DE602007005115T priority patent/DE602007005115D1/de

2007-04-19 Priority to EP07728309A priority patent/EP2012818B1/fr

2007-04-19 Priority to ES07728309T priority patent/ES2341497T3/es

2007-04-19 Priority to JP2009505896A priority patent/JP4947475B2/ja

2007-10-26 Publication of FR2900155A1 publication Critical patent/FR2900155A1/fr

2008-06-27 Application granted granted Critical

2008-06-27 Publication of FR2900155B1 publication Critical patent/FR2900155B1/fr

Status Expired - Fee Related legal-status Critical Current

2026-04-21 Anticipated expiration legal-status Critical

Links

210000000845 cartilage Anatomy 0.000 title abstract 5
241000271566 Aves Species 0.000 title abstract 3
239000011541 reaction mixture Substances 0.000 abstract 3
PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 2
102000035195 Peptidases Human genes 0.000 abstract 2
108091005804 Peptidases Proteins 0.000 abstract 2
PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 abstract 2
229960002591 hydroxyproline Drugs 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000002994 raw material Substances 0.000 abstract 2
FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 abstract 2
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
102000000503 Collagen Type II Human genes 0.000 abstract 1
108010041390 Collagen Type II Proteins 0.000 abstract 1
LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 abstract 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 1
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
229940024606 amino acid Drugs 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
239000007864 aqueous solution Substances 0.000 abstract 1
210000000988 bone and bone Anatomy 0.000 abstract 1
229940059329 chondroitin sulfate Drugs 0.000 abstract 1
YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 abstract 1
238000001035 drying Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 abstract 1
238000001914 filtration Methods 0.000 abstract 1
229920002674 hyaluronan Polymers 0.000 abstract 1
229960003160 hyaluronic acid Drugs 0.000 abstract 1
230000003301 hydrolyzing effect Effects 0.000 abstract 1
QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 abstract 1
230000000415 inactivating effect Effects 0.000 abstract 1
229960000310 isoleucine Drugs 0.000 abstract 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
230000010534 mechanism of action Effects 0.000 abstract 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
230000001954 sterilising effect Effects 0.000 abstract 1
210000001562 sternum Anatomy 0.000 abstract 1
239000004474 valine Substances 0.000 abstract 1
-1 valine (2.7-3.3%) Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/10—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from hair, feathers, horn, skins, leather, bones, or the like
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Immunology (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Toxicology (AREA)
Biophysics (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
Cell Biology (AREA)
Developmental Biology & Embryology (AREA)
Biotechnology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

FR0603547A 2006-04-21 2006-04-21 Hydrolisat de cartilage aviaire, procede d'obtention et utilisations Expired - Fee Related FR2900155B1 (fr)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
FR0603547A FR2900155B1 (fr)	2006-04-21	2006-04-21	Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
US11/455,239 US7671041B2 (en)	2006-04-21	2006-06-19	Hydrolysate of avian cartilage, process of preparation and uses thereof
AT07728309T ATE459371T1 (de)	2006-04-21	2007-04-19	Hydrolysat von vogelknorpel, verfahren zu seiner herstellung und seine verwendungen
DE602007005115T DE602007005115D1 (de)	2006-04-21	2007-04-19	Hydrolysat von vogelknorpel, verfahren zu seiner herstellung und seine verwendungen
PCT/EP2007/053850 WO2007122179A1 (fr)	2006-04-21	2007-04-19	Hydrolysat de cartilage avien, procédé de préparation et utilisation
EP07728309A EP2012818B1 (fr)	2006-04-21	2007-04-19	Hydrolysat de cartilage avien, procédé de préparation et utilisation
ES07728309T ES2341497T3 (es)	2006-04-21	2007-04-19	Hidrolizado de cartilago aviar, procedimiento de preparacion y sus usos.
JP2009505896A JP4947475B2 (ja)	2006-04-21	2007-04-19	鳥軟骨の水解物並びにその調製方法及び使用

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0603547A FR2900155B1 (fr)	2006-04-21	2006-04-21	Hydrolisat de cartilage aviaire, procede d'obtention et utilisations

Publications (2)

Publication Number	Publication Date
FR2900155A1 FR2900155A1 (fr)	2007-10-26
FR2900155B1 true FR2900155B1 (fr)	2008-06-27

Family

ID=37307203

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FR0603547A Expired - Fee Related FR2900155B1 (fr)	2006-04-21	2006-04-21	Hydrolisat de cartilage aviaire, procede d'obtention et utilisations

Country Status (6)

Country	Link
US (1)	US7671041B2 (fr)
JP (1)	JP4947475B2 (fr)
AT (1)	ATE459371T1 (fr)
DE (1)	DE602007005115D1 (fr)
ES (1)	ES2341497T3 (fr)
FR (1)	FR2900155B1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101629517B1 (ko) *	2007-06-01	2016-06-13	교와 핫꼬 바이오 가부시키가이샤	경구 조성물
CN101779733B (zh) *	2010-03-29	2012-12-26	济南环亿生物科技有限公司	一种提高畜禽肌肉中胶原蛋白的饲料添加剂及其生产方法和应用
DE102010060564A1 (de) *	2010-11-15	2012-05-16	Gelita Ag	Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
ES2403804B1 (es) *	2011-09-21	2014-07-15	Bioib�Rica, S.A.	Producto de cartílago.
WO2012143324A1 (fr)	2011-04-19	2012-10-26	Bioiberica, S.A.	Produit de cartilage
CN102690372B (zh) *	2012-05-16	2014-04-23	中国农业科学院农产品加工研究所	一种鸡骨架联产脱骨原料肉、鸡骨高汤及硫酸软骨素的方法
EP2900808B1 (fr)	2012-09-28	2019-04-03	Scripps Health	Procédés de différenciation de cellules souches en chondrocytes
JP6324395B2 (ja)	2012-10-29	2018-05-16	スクリップスヘルス	軟骨細胞を移植する方法
JP6399558B2 (ja)	2012-10-29	2018-10-03	スクリップスヘルス	軟骨細胞から多能性幹細胞を製造する方法
US11478504B2 (en)	2013-07-08	2022-10-25	International Dehydrated Foods, Inc.	Compositions and methods for preventing/treating metabolic syndrome
JP2016523966A (ja)	2013-07-08	2016-08-12	インターナショナルディハイドレーティッドフーズ，インコーポレイテッド	家禽から調製した組成物およびその使用方法
AU2014202041B8 (en) *	2013-10-24	2020-04-02	Lonza Greenwood Llc	Method of reducing exercise-induced joint pain in non-arthritic mammals
WO2017165281A1 (fr)	2016-03-22	2017-09-28	Avicenna Nutraceutical, Llc	Compositions de collagène hydrolysé et leurs procédés de fabrication
US11702447B2 (en)	2017-05-11	2023-07-18	Avicenna Nutraceutical, Inc.	Methods for producing collagen
BR112020004053A2 (pt) *	2017-08-31	2020-09-01	Lonza Llc	composição de promoção da saúde e métodos de uso de suplementos
US20190100785A1 (en) *	2017-10-03	2019-04-04	Robert den Hoed	Method of producing undenatured collagen from cartilage with low temperature hydrolysis
JP2023508934A (ja) *	2019-12-27	2023-03-06	サントリーホールディングス株式会社	環状ジペプチド、プリンヌクレオチド及び／又はアミノ酸とチキンエキスとを含む組成物、その製造方法、並びに、環状ジペプチド、プリンヌクレオチド及び／又はアミノ酸、並びにチキンエキスの使用
CN115151140A (zh) *	2019-12-27	2022-10-04	三得利控股株式会社	含有肽和/或其盐的食品或饮料组合物、其生产方法、经水解的ii型胶原的用途、抑制骨吸收的组合物以及鸡提取物的用途
WO2021131104A1 (fr) *	2019-12-27	2021-07-01	Suntory Holdings Limited	Composition contenant un peptide, son procédé de production et utilisation du peptide
WO2023213909A1 (fr)	2022-05-04	2023-11-09	Rousselot Bv	Composition d'hydrolysat de collagène pour réduire des douleurs articulaires après un exercice

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6025327A (en) *	1997-08-08	2000-02-15	Biocell Technology, Llc	Hydrolyzed collagen type II and use thereof
US6780841B2 (en) *	2001-11-13	2004-08-24	Biocell Technology, Llc	Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same
JP4436084B2 (ja) *	2003-08-04	2010-03-24	日本メナード化粧品株式会社	コラーゲン産生促進剤及びコラーゲン架橋形成阻害剤
WO2005014622A2 (fr) *	2003-08-07	2005-02-17	F. Hoffmann-La Roche Ag	Peptides antigeniques de l'arthrite rhumatoide
AU2004272066B8 (en) *	2003-09-11	2010-08-05	Genentech, Inc.	Methods of using WISP antagonists
EP1709171A2 (fr) *	2003-11-06	2006-10-11	Novartis AG	Clonage et caracterisation de regions flanquantes 5' d'un gene d'aggrecanase-1 humain
JP2005314265A (ja) *	2004-04-28	2005-11-10	Nippon Menaade Keshohin Kk	老化防止剤

2006
- 2006-04-21 FR FR0603547A patent/FR2900155B1/fr not_active Expired - Fee Related
- 2006-06-19 US US11/455,239 patent/US7671041B2/en active Active
2007
- 2007-04-19 JP JP2009505896A patent/JP4947475B2/ja active Active
- 2007-04-19 DE DE602007005115T patent/DE602007005115D1/de active Active
- 2007-04-19 ES ES07728309T patent/ES2341497T3/es active Active
- 2007-04-19 AT AT07728309T patent/ATE459371T1/de active

Also Published As

Publication number	Publication date
DE602007005115D1 (de)	2010-04-15
US20070293427A1 (en)	2007-12-20
ES2341497T3 (es)	2010-06-21
ATE459371T1 (de)	2010-03-15
JP2009536923A (ja)	2009-10-22
FR2900155A1 (fr)	2007-10-26
US7671041B2 (en)	2010-03-02
JP4947475B2 (ja)	2012-06-06

Legal Events

Date	Code	Title	Description
2016-04-18	PLFP	Fee payment	Year of fee payment: 11
2017-04-07	PLFP	Fee payment	Year of fee payment: 12
2018-04-13	PLFP	Fee payment	Year of fee payment: 13
2019-04-11	PLFP	Fee payment	Year of fee payment: 14
2020-04-30	PLFP	Fee payment	Year of fee payment: 15
2021-04-27	PLFP	Fee payment	Year of fee payment: 16
2022-01-14	CA	Change of address	Effective date: 20211203
2022-01-14	CD	Change of name or company name	Owner name: DIANA FOOD, FR Effective date: 20211203
2022-12-30	ST	Notification of lapse	Effective date: 20221205

Publication	Publication Date	Title
FR2900155B1 (fr)	2008-06-27	Hydrolisat de cartilage aviaire, procede d'obtention et utilisations
Mochizuki et al.	2003	Laminin‐1 peptide‐conjugated chitosan membranes as a novel approach for cell engineering
Feng et al.	2017	Transepithelial transport efficiency of bovine collagen hydrolysates in a human Caco-2 cell line model
UA89616C2 (ru)	2010-02-25	Гидролизат казеина, способ его получения и применения
CN107630060B (zh)	2021-06-15	自组装胶原蛋白及其制备方法
CN100369929C (zh)	2008-02-20	海蜇胶原蛋白及其制备方法
CN1555393A (zh)	2004-12-15	角蛋白基产品及其生产方法
WO2009142441A3 (fr)	2010-03-04	Procédé de production d'hydrolysat de gluten de maïs et hydrolysat de gluten de maïs l'utilisant
US20100286368A1 (en)	2010-11-11	Novel polypeptide and process for producing the same
CN102676620B (zh)	2013-11-27	一种高分子量鱿鱼皮胶原蛋白的制备方法
Heck et al.	2007	Enzyme‐catalyzed formation of β‐peptides: β‐peptidyl aminopeptidases BapA and DmpA acting as β‐peptide‐synthesizing enzymes
DE60314526D1 (de)	2007-08-02	Modifizierte lupinproteine zur herstellung einer wasser-dispergierbaren produktform fettlöslicher stoffe
CN107630059B (zh)	2021-06-15	新型自组装胶原蛋白及制备方法
CN1927435A (zh)	2007-03-14	去除甲醛的材料
CN107630058B (zh)	2021-06-15	一种新型自组装胶原蛋白及制备方法
Li et al.	2023	Effective biodegradation on chicken feather by the recombinant KerJY-23 Bacillus subtilis WB600: A synergistic process coupled by disulfide reductase and keratinase
CN105602481A (zh)	2016-05-25	一种本体型高强度仿生粘合剂的制备方法
KR20040108147A (ko)	2004-12-23	어류 비늘을 이용한 단백질 가수분해물의 제조방법
CN1958781A (zh)	2007-05-09	一种试剂蛋白胨及其制备方法
WO2007059874A3 (fr)	2007-11-15	Compositions pour traiter l'arthrose et nourrir le liquide synovial
NZ603012A (en)	2015-01-30	Preparation of polypeptides and salts thereof
CN105920675A (zh)	2016-09-07	一种制备生物功能化壳聚糖水凝胶的方法
CN1712516A (zh)	2005-12-28	一种蛋白胨及其制备方法
CA3056759C (fr)	2024-01-23	Compositions de collagene hydrolyse et leurs procedes de fabrication
BRPI0805852A8 (pt)	2021-06-29	polímeros ácidos protéicos, processos de produção, uso de polímeros ácidos protéicos, composição farmacêutica e método de tratamento